Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hendrien Kuipers

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Hepatology (Baltimore, Md.)|December 16, 2024
Drink less, be your bestHendrien Kuipers
Hepatology (Baltimore, Md.)|April 18, 2025
Food for thought: The EAT-Lancet diet to prevent a fatty liverHendrien Kuipers
Hepatobiliary Surgery and Nutrition|June 11, 2026
Transplantation for unresectable perihilar cholangiocarcinoma beyond the Mayo protocol: a challenge for SUREHendrien Kuipers, Rory L Smoot, Frederik J H Hoogwater
BMJ Case Reports|August 19, 2024
Protein-losing enteropathy as a result of colon polyposis and colon cancer: a multidisciplinary approach to diagnosis and treatmentHendrien Kuipers, Henderik L van Westreenen, Freek C P Moll, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|August 25, 2020
Clinical value of diffusion-weighted MRI for differentiation between benign and malignant gallbladder disease: a systematic review and meta-analysisHendrien Kuipers, Frederik Jh Hoogwater, Gea A Holtman, et al.
European Journal of Radiology|March 6, 2021
Diagnostic performance of preoperative CT in differentiating between benign and malignant origin of suspicious gallbladder lesionsHendrien Kuipers, Frederik J H Hoogwater, Gea A Holtman, et al.
Cells|October 15, 2025
The Protein Tyrosine Phosphatase 1B Modulates the Activation of Yes-Associated Protein and Sensitizes to Cytotoxic Chemotherapy in Preclinical Models of CholangiocarcinomaRyan D Watkins, Jennifer L Tomlinson, EeeLN H Buckarma, et al.
Cancers|November 13, 2021
Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic ImplicationsHendrien Kuipers, Tessa J J de Bitter, Marieke T de Boer, et al.
Future Oncology (London, England)|July 28, 2025
A Phase 1 study of the novel GCN2 kinase activator NXP800 in patients with advanced cholangiocarcinomaHendrien Kuipers, Joseph J Larson, Caitlin B Conboy, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2019
Delta peritoneal cancer index (ΔPCI): A new dynamic prognostic parameter for survival in patients with colorectal peritoneal metastasesJudith E K R Hentzen, Willemijn Y van der Plas, Hendrien Kuipers, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Hepatology (Baltimore, Md.)|December 16, 2024
Drink less, be your bestHendrien Kuipers
Hepatology (Baltimore, Md.)|April 18, 2025
Food for thought: The EAT-Lancet diet to prevent a fatty liverHendrien Kuipers
Hepatobiliary Surgery and Nutrition|June 11, 2026
Transplantation for unresectable perihilar cholangiocarcinoma beyond the Mayo protocol: a challenge for SUREHendrien Kuipers, Rory L Smoot, Frederik J H Hoogwater
BMJ Case Reports|August 19, 2024
Protein-losing enteropathy as a result of colon polyposis and colon cancer: a multidisciplinary approach to diagnosis and treatmentHendrien Kuipers, Henderik L van Westreenen, Freek C P Moll, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|August 25, 2020
Clinical value of diffusion-weighted MRI for differentiation between benign and malignant gallbladder disease: a systematic review and meta-analysisHendrien Kuipers, Frederik Jh Hoogwater, Gea A Holtman, et al.
European Journal of Radiology|March 6, 2021
Diagnostic performance of preoperative CT in differentiating between benign and malignant origin of suspicious gallbladder lesionsHendrien Kuipers, Frederik J H Hoogwater, Gea A Holtman, et al.
Cells|October 15, 2025
The Protein Tyrosine Phosphatase 1B Modulates the Activation of Yes-Associated Protein and Sensitizes to Cytotoxic Chemotherapy in Preclinical Models of CholangiocarcinomaRyan D Watkins, Jennifer L Tomlinson, EeeLN H Buckarma, et al.
Cancers|November 13, 2021
Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic ImplicationsHendrien Kuipers, Tessa J J de Bitter, Marieke T de Boer, et al.
Future Oncology (London, England)|July 28, 2025
A Phase 1 study of the novel GCN2 kinase activator NXP800 in patients with advanced cholangiocarcinomaHendrien Kuipers, Joseph J Larson, Caitlin B Conboy, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2019
Delta peritoneal cancer index (ΔPCI): A new dynamic prognostic parameter for survival in patients with colorectal peritoneal metastasesJudith E K R Hentzen, Willemijn Y van der Plas, Hendrien Kuipers, et al.
Pageof 2